• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno .

作者信息

Liew Jean W, Graef Elizabeth R, Sparks Jeffrey A, Kim Alfred Hyoungju

机构信息

Division of Rheumatology, Boston University, Boston, Massachusetts, USA.

Division of Rheumatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

出版信息

Ann Rheum Dis. 2022 Aug;81(8):e155. doi: 10.1136/annrheumdis-2020-218432. Epub 2020 Jul 9.

DOI:10.1136/annrheumdis-2020-218432
PMID:32647030
Abstract
摘要

相似文献

1
Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno .对桑托斯-莫雷诺的《新冠疫情期间患者对服用抗疟药的恐惧引发的紧急情况：抗疟药对心血管健康的危害真如近期报道所言那般严重吗？》一文的回应
Ann Rheum Dis. 2022 Aug;81(8):e155. doi: 10.1136/annrheumdis-2020-218432. Epub 2020 Jul 9.
2
Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?在新冠疫情期间，患者因害怕服用抗疟药而引发的紧急情况：抗疟药对心血管健康的危害是否真如近期报道所言那般严重？
Ann Rheum Dis. 2022 Aug;81(8):e154. doi: 10.1136/annrheumdis-2020-218259. Epub 2020 Jul 9.
3
Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.为何您的患者认为羟氯喹和氯喹对新冠病毒病有90%的疗效是极其危险的。
J Clin Pharmacol. 2020 Aug;60(8):949-953. doi: 10.1002/jcph.1687. Epub 2020 Jul 1.
4
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.羟氯喹和氯喹相关心血管不良事件：COVID-19 前报告的综合药物警戒分析。
Br J Clin Pharmacol. 2021 Mar;87(3):1432-1442. doi: 10.1111/bcp.14546. Epub 2020 Sep 22.
5
Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.氯喹和羟氯喹在2019冠状病毒病中的应用及其心血管影响：理解安全性差异以改进临床试验的解读与设计
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008688. doi: 10.1161/CIRCEP.120.008688. Epub 2020 May 21.
6
Concentration-dependent mortality of chloroquine in overdose.氯喹过量致浓度依赖性死亡率。
Elife. 2020 Jul 8;9:e58631. doi: 10.7554/eLife.58631.
7
Regulators split on antimalarials for COVID-19.监管机构在用于治疗新冠肺炎的抗疟疾药物问题上存在分歧。
Lancet. 2020 Apr 11;395(10231):1179. doi: 10.1016/S0140-6736(20)30817-5.
8
Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine.监测服用羟氯喹和氯喹患者的视网膜毒性。
Rheumatology (Oxford). 2019 Jan 1;58(1):3-4. doi: 10.1093/rheumatology/key024.
9
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.COVID-19 药物治疗的心脏安全性：综述及建议监测方案。
Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):215-221. doi: 10.1177/2048872620922784. Epub 2020 May 6.
10
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.用于治疗新冠肺炎的氯喹/羟氯喹引发室性心律失常的风险：是否应该使用该药？
Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27.